Cargando…

Haematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis: Recent Advances

PURPOSE OF REVIEW: Autologous haematopoietic stem cell transplantation (AHSCT) is increasingly considered a treatment option for patients with multiple sclerosis (MS), an autoimmune demyelinating and degenerative disease of the central nervous system (CNS). AHSCT persistently suppresses inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mariottini, Alice, De Matteis, Eleonora, Cencioni, Maria Teresa, Muraro, Paolo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468923/ https://www.ncbi.nlm.nih.gov/pubmed/37589918 http://dx.doi.org/10.1007/s11910-023-01290-2

Ejemplares similares

Autologous haematopoietic stem cell transplantation versus low‐dose immunosuppression in secondary–progressive multiple sclerosis
por: Mariottini, Alice, et al.
Publicado: (2022)

Antibody-mediated cell depletion therapies in multiple sclerosis
por: Mariottini, Alice, et al.
Publicado: (2022)

The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Willison, A. G., et al.
Publicado: (2022)

Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline
por: Bayas, Antonios, et al.
Publicado: (2023)

Haematopoietic stem cell transplantation in systemic sclerosis
por: Walker, Ulrich A, et al.
Publicado: (2018)

Correction to: The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Willison, A. G., et al.
Publicado: (2022)

Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party
por: Cencioni, Maria Teresa, et al.
Publicado: (2022)

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper
por: Saccardi, R, et al.
Publicado: (2012)

Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
por: Burman, Joachim, et al.
Publicado: (2023)

Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis
por: Massey, Jennifer, et al.
Publicado: (2022)

Chronic inflammatory demyelinating polyradiculoneuropathy occurring after autologous haematopoietic stem cell transplantation for multiple sclerosis
por: Simonsen, Cecilia Smith, et al.
Publicado: (2016)

Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study
por: Zhukovsky, Christina, et al.
Publicado: (2021)

A global online study of haematopoietic stem cell transplantation in multiple sclerosis and other neurodegenerative disorders
por: Panegyres, Peter K., et al.
Publicado: (2022)

Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis: a Review of Current Literature and Future Directions for Transplant Haematologists and Oncologists
por: Das, Joyutpal, et al.
Publicado: (2019)

Worse Physical Disability Is Associated With the Expression of PD-1 on Inflammatory T-Cells in Multiple Sclerosis Patients With Older Appearing Brains
por: Jacobs, Sophie A. H., et al.
Publicado: (2022)

In Utero Haematopoietic Stem Cell Transplantation (IUHSCT)
por: Renda, Maria Concetta, et al.
Publicado: (2009)

Second autologous haematopoietic stem cell transplantation in systemic sclerosis—a case report
por: van Rhijn-Brouwer, Femke C C, et al.
Publicado: (2019)

Autologous Haematopoietic Stem Cell Transplantation and Systemic Sclerosis: Focus on Interstitial Lung Disease
por: Bagnato, Gianluca, et al.
Publicado: (2022)

Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation
por: Ayoglu, Burcu, et al.
Publicado: (2023)

Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation
por: Hendrawan, Kevin, et al.
Publicado: (2022)

Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis
por: Das, J, et al.
Publicado: (2021)

Advances in the use of stem cell transplants in the treatment of multiple sclerosis
por: Thomas, Rachel, et al.
Publicado: (2022)

Recent advances in the treatment of multiple sclerosis
por: Bennett, Jeffrey L, et al.
Publicado: (2010)

Expansion of Haematopoietic Stem and Progenitor Cells: Paving the Way for Next-Generation Haematopoietic Stem Cell Transplantation
por: Bari, Sudipto, et al.
Publicado: (2019)

Haematopoietic Stem Cell Transplantation and the Price to Pay For
por: Maffulli, N.
Publicado: (2013)

Autologous haematopoietic stem cell transplantation for neurological diseases
por: Burman, Joachim, et al.
Publicado: (2018)

Thrombotic microangiopathy following haematopoietic stem cell transplant
por: Seaby, Eleanor G., et al.
Publicado: (2017)

Haematopoietic Stem Cell Transplantation for Primary Haemophagocytic Lymphohistiocytosis
por: Lehmberg, Kai, et al.
Publicado: (2019)

Noninfectious pulmonary complications of haematopoietic stem cell transplantation
por: Haider, Samran, et al.
Publicado: (2020)

Haematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
por: Slatter, M. A., et al.
Publicado: (2023)

Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
por: Sharrack, Basil, et al.
Publicado: (2019)

Outcomes of haematopoietic stem cell transplant patients admitted to the ICU
por: Bird, G, et al.
Publicado: (2011)

Doxycycline for haematopoietic stem cell transplantation-related thrombotic microangiopathy
por: Izzedine, Hassane, et al.
Publicado: (2010)

Clinical efficacy of haematopoietic stem cell transplantation for adult adrenoleukodystrophy
por: Matsukawa, Takashi, et al.
Publicado: (2020)

Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma
por: Abeyakoon, Chathuri, et al.
Publicado: (2020)

Identification of the minimum requirements for successful haematopoietic stem cell transplantation
por: Nishi, Katsuyuki, et al.
Publicado: (2021)

Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia
por: Gratwohl, Alois, et al.
Publicado: (2019)

Recent advances in understanding multiple sclerosis
por: Stys, Peter K., et al.
Publicado: (2019)

Immunosenescence and Autoimmunity: Exploiting the T-Cell Receptor Repertoire to Investigate the Impact of Aging on Multiple Sclerosis
por: Amoriello, Roberta, et al.
Publicado: (2021)

Quantitative tracking of T cell clones after haematopoietic stem cell transplantation
por: Mamedov, Ilgar Z, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dmcthd8bp6srvksrts3to1gj69